Trending...
- Five Aster Awards! Fusion Marketing Group Brings Home Big Wins in 2025!
- 14th CryptoSuper500 Report Releases: Bitcoin's Evolution into a Global Supercomputer
- Various Measures Introduced to and Approved by The Chicago City Council
CHICAGO, Oct. 8, 2024 ~ Chicago, IL - Axtria Inc., a global leader in cloud software and data analytics for the life sciences industry, showcased its leadership in driving innovative solutions for pharmaceutical companies at the PMSA 2024 Fall Symposium. The two-day summit, held on October 3-4, 2024, brought together industry leaders, researchers, and academics to explore the transformative impact of AI in healthcare.
During the conference, Axtria received several awards for its thought leadership presentations and participated as a gold sponsor, reaffirming its commitment to exchanging knowledge and enhancing the impact of AI in the pharmaceutical industry.
Sudip Chakraborty, Principal and Head of AI/GenAI at Axtria, stated that "At Axtria, we believe that AI is not just a tool but a transformative force that can reshape the pharmaceutical landscape." He also emphasized their dedication to partnering with industry leaders to harness AI-driven insights and solutions that improve decision-making, optimize field operations, and ultimately enhance patient outcomes.
More on illi News
Axtria's experts collaborated with client partners to lead insightful presentations and discussions on advanced AI-driven solutions and strategies tailored for the pharmaceutical industry. Some of these sessions included:
- A case study presented by Axtria and Gilead Sciences on "Nuances of Leveraging Generative AI for Structured Data Processing and Insights." This highlighted the importance of empowering non-technical users to access insights through natural language generation-based applications. These GenAI-powered tools provide intuitive user interfaces with robust data access controls, enabling broader access to critical insights.
- A collaboration between Axtria and Astellas Pharma on "AI-Enabled Action Alerts to Enhance Field Effectiveness." This session demonstrated how AI-powered recommendations are transforming field operations by providing representatives with actionable insights to optimize their engagements, increase prescription uptake (Rx), and enhance overall brand performance. It showcased how Astellas and Axtria worked together to leverage data, convert it into useful rep suggestions, and ultimately improve brand performance through better field execution.
More on illi News
- A discussion with Bayer on "Utilizing AI to Identify Unrealized Opportunities and Optimize End-to-End Field Force Operations." This session explored Bayer's AI-driven transformation of field force operations across design, planning, execution, and talent management. It showcased the tangible business impact of AI.
- A workshop led by Axtria on "Enabling EDA Automation for Commercial Analytics using LLM." This demonstrated how generative AI can automate exploratory data analysis (EDA) processes, transforming raw data into actionable insights. Additionally, Axtria also conducted a focus session on "Accelerating Pharma Business Analytics with AI-Ready Data Products Strategy," where they shared how AI-ready data products can streamline data management, unify fragmented data landscapes, and accelerate analytics while reducing operational costs.
Axtria's participation in the PMSA 2024 Fall Symposium highlighted their commitment to driving innovation in the pharmaceutical industry through the use of AI. Their thought leadership presentations and collaborations with client partners showcased their expertise in harnessing the power of AI to improve decision-making and enhance overall business performance.
During the conference, Axtria received several awards for its thought leadership presentations and participated as a gold sponsor, reaffirming its commitment to exchanging knowledge and enhancing the impact of AI in the pharmaceutical industry.
Sudip Chakraborty, Principal and Head of AI/GenAI at Axtria, stated that "At Axtria, we believe that AI is not just a tool but a transformative force that can reshape the pharmaceutical landscape." He also emphasized their dedication to partnering with industry leaders to harness AI-driven insights and solutions that improve decision-making, optimize field operations, and ultimately enhance patient outcomes.
More on illi News
- New Study Reveals Nearly Half Of TikTok Shop Stores Generate Zero Sales Despite Platform's $100 Million Black Friday Success
- Speranza Dental Implant Centers Opens Their First Location
- New Formulations of GLP-1s Demonstrate Positive Results, Potentially Offering Additional Options for Obesity Medications
- Erin Borst Crowned Winner of eATLAS' 2025 Flavors of Chicago Scavenger Hunt
- Chicago: Mayor Brandon Johnson Announces Juneteenth Task Force Members
Axtria's experts collaborated with client partners to lead insightful presentations and discussions on advanced AI-driven solutions and strategies tailored for the pharmaceutical industry. Some of these sessions included:
- A case study presented by Axtria and Gilead Sciences on "Nuances of Leveraging Generative AI for Structured Data Processing and Insights." This highlighted the importance of empowering non-technical users to access insights through natural language generation-based applications. These GenAI-powered tools provide intuitive user interfaces with robust data access controls, enabling broader access to critical insights.
- A collaboration between Axtria and Astellas Pharma on "AI-Enabled Action Alerts to Enhance Field Effectiveness." This session demonstrated how AI-powered recommendations are transforming field operations by providing representatives with actionable insights to optimize their engagements, increase prescription uptake (Rx), and enhance overall brand performance. It showcased how Astellas and Axtria worked together to leverage data, convert it into useful rep suggestions, and ultimately improve brand performance through better field execution.
More on illi News
- Chicago Is Joined by Major Cities in Challenging the Department of Homeland Security for Freezing Critical Counterterrorism Funds
- Naperville Police Participate in Independence Day Traffic Safety Campaign
- WWSG Announces Exclusive Speaking Partnership with Former Australian Prime Minister Tony Abbott
- Aidaptive and BizCor Expand Inhabit Partnership with Native Enterprise-Grade Search for Streamline Customers
- Pikmykid Partners with Vivi to Enhance School Emergency Communication and Safety
- A discussion with Bayer on "Utilizing AI to Identify Unrealized Opportunities and Optimize End-to-End Field Force Operations." This session explored Bayer's AI-driven transformation of field force operations across design, planning, execution, and talent management. It showcased the tangible business impact of AI.
- A workshop led by Axtria on "Enabling EDA Automation for Commercial Analytics using LLM." This demonstrated how generative AI can automate exploratory data analysis (EDA) processes, transforming raw data into actionable insights. Additionally, Axtria also conducted a focus session on "Accelerating Pharma Business Analytics with AI-Ready Data Products Strategy," where they shared how AI-ready data products can streamline data management, unify fragmented data landscapes, and accelerate analytics while reducing operational costs.
Axtria's participation in the PMSA 2024 Fall Symposium highlighted their commitment to driving innovation in the pharmaceutical industry through the use of AI. Their thought leadership presentations and collaborations with client partners showcased their expertise in harnessing the power of AI to improve decision-making and enhance overall business performance.
Filed Under: Business
0 Comments
Latest on illi News
- Anti-war groups protest vs US-NATO actions in Gaza, Iran, the Global South
- Dr. Jacqueline West Honored as Best Dentist in JAX by Folio Weekly
- Naperville Police Investigate Fatal Traffic Crash at Chicago Avenue and Naper Boulevard
- The American Diabetes Association Demonstrates Its Commitment to Curbing the Obesity Epidemic with Obesity Standards of Care
- Exciting News: Pivotal Health Solutions Acquires Revolutionary Portable Parallel Bars
- Miboxer Achieved New Goal in GILE 2025
- Jeopardy!'s Ken Jennings Headlines National Mensa Event
- Mensa Foundation Prize Awarded to Neuroscientist-Pianist
- New book, "High-Tech Heroes," redefines billionaire as someone who improves a billion lives
- Durex Products Wire Cloth Screen Media: Engineered for Maximum Performance and Durability
- OPRAH.COM Featured Award-Winning Novel AS FAR AS YOU GO BEFORE YOU HAVE TO COME BACK now Available as Audiobook
- How Kallie Boxell Helps Texas Companies Solve the Talent Equation
- Naperville: Structure Fire in the 1500 Block of West Jefferson Avenue
- KeysCaribbean Vacation Home Rentals Offers Last-Minute Booking Discount of 15 Percent
- purelyIV Blog Named One of the Top 45 IV Therapy Blogs by Feedspot
- purelyIV Launches Mobile Iron Infusion Therapy for Patients with Iron Deficiency Anemia
- Zhang Financial Sponsors Distinguished Juror Li-Wei Qin and Historic Instrument Selection for Stulberg's 50th Anniversary
- Smile Makers Dental Care Introduces FP1: East Bay's First Robotic-Assisted Full-Arch Implant Solution for Natural, Fixed Smiles
- DCAS College opens new Representative Office in Malaysian Capital Kuala Lumpur
- GMO Miner: Creating a simple, efficient and reliable new cloud mining experience